# Drug Interaction - Oral Contraceptive

> **NCT00399685** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 28 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Ortho Tri-Cyclen LO
- **DRUG:** Ortho Cyclen
- **DRUG:** Ortho Cyclen + Efavirenz
- **DRUG:** Ortho Cyclen

## Key facts

- **NCT ID:** NCT00399685
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2011-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00399685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00399685, "Drug Interaction - Oral Contraceptive". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00399685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*